Zepbound, when covered, may appear on the specialty tier
Major medical and endocrine societies recommend stopping GLP-1 medications before pregnancy and using other diabetes or weight-management strategies that are known to be safer in pregnancy when needed
In addition I have never experienced any side effects
Please note, there is a separate fee for this initial assessment
Seek immediate medical attention if you experience severe weakness, inability to move, dark urine, fever, or persistent pain beyond 2 weeks that does not improve with rest and over-the-counter pain relief
DOI: doi: 10.1038/s41556-023-01157-1 The HASTER lncRNA promoter is a cis-acting transcriptional stabilizer of HNF1A Beucher A, Miguel-Escalada I, Balboa D et al